Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleGene therapy approval may be rocky road for industry.AuthorsGavaghan, HelenAbstractTalks about the possibility of a tough relationship to be faced by the biotechnology industry and Recombinant DNA Advisory Committee of the US National Institute of Health as the gene therapy moves down the clinical pipeline in US.SubjectsUNITED States; GENE therapy; NATIONAL Institutes of Health (U.S.). Recombinant DNA Advisory Committee; BIOTECHNOLOGY industries; GOVERNMENT policyPublicationNature, 1995, Vol 374, Issue 6519, p202ISSN0028-0836Publication typeArticleDOI10.1038/374202a0